TFF Pharmaceuticals, Inc.

NASDAQ:TFFP

1.63 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q3
Revenue 0.650.2030.73400.3330.05100000000000000000
Cost of Revenue 0.1410.140.1310.1250.1240.1230.1210.1010.0890.0770.0770.0280.0040.001000000000
Gross Profit 0.510.0630.603-0.1250.21-0.072-0.121-0.101-0.089-0.077-0.077-0.028-0.004-0.001000000000
Gross Profit Ratio 0.7840.310.82200.629-1.39500000000000000000
Reseach & Development Expenses 2.5883.5562.9742.3872.6824.0194.1364.0265.1115.2626.926.342.7625.2783.0552.8242.5682.2363.2682.5641.321.6710.14
General & Administrative Expenses 2.0242.322.5092.2692.673.1193.5583.3423.693.2463.1882.3882.3512.6472.8642.2551.2751.6181.4440.3010.8890.5320.466
Selling & Marketing Expenses -0.141-0.14-0.13100000000000000000000
SG&A 1.8842.2982.3782.2692.673.1193.5583.3423.693.2463.1882.3882.3512.6472.8642.2551.2751.6181.4440.3010.8890.5320.466
Other Expenses 000.166-0.077-0.037-0.051-0.313-0.0880.0210.0570.037-0.0130.4420.231000000000
Operating Expenses 4.4725.8545.3524.4215.0197.0867.3817.2818.7738.4410.0968.6785.1117.9015.9195.0793.8433.8534.7122.8642.2092.2020.606
Operating Income -4.613-5.994-5.483-4.421-5.019-7.086-7.381-7.281-8.773-8.44-10.096-8.678-5.111-7.901-5.919-5.079-3.843-3.853-4.712-2.864-2.209-2.202-0.606
Operating Income Ratio -7.094-29.488-7.4710-15.056-137.79100000000000000000
Total Other Income Expenses Net 0.1340.2590.721-0.077-0.0370.0350.0080.0060.0210.0570.037-0.0130.4420.2310.0240.0210.0260.0560.050.0260.0220.020.021
Income Before Tax -4.479-5.735-4.762-4.409-5.02-7.051-7.373-7.275-8.746-8.376-10.05-8.679-4.656-7.655-5.895-5.058-3.817-3.797-4.662-2.838-2.187-2.183-0.585
Income Before Tax Ratio -6.889-28.214-6.4890-15.06-137.10900000000000000000
Income Tax Expense -0-00-0.089-0.036-0.1580.006-0.006-0.006-0.007-0.01-0.012-0.014-0.017-0.055-0.053-0.051-0.047-0.046-0.045-0.041-0.040
Net Income -4.479-5.735-4.762-4.409-5.02-6.893-7.379-7.268-8.746-8.376-10.05-8.679-4.656-7.655-5.895-5.058-3.817-3.797-4.662-2.838-2.187-2.183-0.585
Net Income Ratio -6.889-28.214-6.4890-15.06-134.03200000000000000000
EPS -1.22-2.4-2.01-2.32-3.47-4.76-5.1-0.29-0.34-0.33-0.4-0.34-0.18-0.33-0.26-0.24-0.2-0.2-0.33-0.16-0.12-0.12-0.033
EPS Diluted -1.22-2.4-2.01-2.32-3.47-4.76-5.1-0.29-0.34-0.33-0.4-0.34-0.18-0.33-0.26-0.24-0.2-0.2-0.33-0.16-0.12-0.12-0.033
EBITDA -4.472-5.854-5.352-4.295-4.895-7.086-7.26-7.179-8.684-8.363-10.019-8.649-5.107-7.901-5.919-5.079-3.843-3.853-4.712-2.864-2.209-2.202-0.606
EBITDA Ratio -6.878-28.799-7.2930-14.685-137.79100000000000000000